medicalxpress - Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond physical functioning, erecti…
AI Summary: Researchers are advancing alternatives to sildenafil-era approaches for erectile disorder, exploring new biological targets and therapies that aim to restore function rather than just patch symptoms. The coverage explains emerging mechanisms, investigational treatments and the shifting clinical landscape—because sometimes a Band-Aid on performance isn’t the long-term plan.
Mid‑stage Parkinson trial failure halts drug development plans / 8 days
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 6 wks
First-in-human trial primes immune system to accept donor livers / 6 wks
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 7 wks
Keratin 16 restrains skin inflammation and may guide treatments / 7 wks
Avalyn upsizes IPO to raise cash for lung drug trials / 29 days
Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 6 wks
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.